Loading insider details...
Beta
Latest Form 4 (Aug 17, 2026): Sale of 2,007 RYTM shares, $233.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 17, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale | 2,007 | $233.0K |
| Jul 2, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 4,445 | n/a |
| Feb 13, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/Award | 16,650 | n/a |
| Feb 3, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 6,663 | n/a |
| Jul 3, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 4,445 | n/a |
| Feb 20, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/Award | 26,650 | n/a |
| Jul 10, 2024 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/Award | 53,333 | n/a |